The Canary Capital has filed a sixth suggested fund that has been exchanged by the Crypto Exchange (ETF) with US regulators, at this time for a monitoring of the crypto token area of the Sui crypto token.
In a March 17 form S-1 File At the Securities and Exchange Commission, the Crypto Investment Firm asked to list the Canary Sui ETF, which excludes information on what it exchanges or the suggested ticker symbol.
ETF is holding sui directly (Sui). per Coingekco.
SUI traded 1.3% on the last day up to $ 2.31 and gained 7.3% on Sunday. However, it dropped 56.5% from its all-time peak of $ 5.35.
Sui’s price in the last 24 hours hit a high $ 2.38 but since slightly collapsed. Source: Coingekco
Canary registered a confidence in Delaware on March 6 for the fund, and it should also file form 19B-4 with the SEC before the agency considers it if it is listing for trading.
Canary filing is the antifty Crypto etf bid Includes Sec. In recent months, It filed For tracking ETFS Solana (Sol), Litecoin (LTC), XRP (XRP) Hedera (Hbar) and axlar (Axl).
File will come after Sui said on March 6th that It has partnered with World Liberty Financial, the Crypto platform supported by US President Donald Trump.
Part of Partnership Saw World Liberty with SUI token in the so -called “Macro Strategy” Token Reserve and explore additional product opportunities together.
Related: Hashdex supports S-1 for Crypto Index ETF, adding seven Altcoins
Trump has pledged to relax regulation of implementation against the crypto, which has led to a fuzzy cries of Crypto ETF in the midst of the SEC under his administration will move to the greenlight with them.
The SEC has Delayed decisions In multiple Crypto ETF filings, but Commissioner Hester Peirce said last month that The agency will wait Until the Senate confirmed Trump’s choice to head to the SEC, Paul Atkinsbefore deciding on an agenda for crypto.
A Senate Confirmation hearing for Atkins is reported to have ended For March 27, delayed due to issues with financial disclosure.
Magazine: Crypto fans are obsessed with longevity and biohacking – here’s why
